Impulse News

Impulse Dynamics Successfully Launches the Optimizer® Smart Device for Heart Failure Treatment in Europe

Impulse Dynamics has launched the next generation of its Optimizer® device, the Optimizer® Smart, in Europe after it received the CE mark. The Optimizer® Smart is a minimally invasive implantable device designed to treat chronic heart failure (CHF) in patients that are symptomatic despite appropriate medical therapy. The device is based on novel cardiac contractility […]

Mehr dazu

Impulse Dynamics Recognized with Frost & Sullivan’s 2016 New Product Innovation Award

September 12, 2016 – Impulse Dynamics, developer of the Optimizer® IVs implantable device for the treatment of Chronic Heart Failure (CHF), is the recipient of the prestigious Frost & Sullivan 2016 European Chronic Heart Failure Therapy New Product Innovation Award. Based on a recent analysis of the European chronic heart failure therapy market, Frost & […]

Mehr dazu

CCM™ Therapy presented by Charité Berlin at the 2016 Heart Failure Annual Meeting

Stuttgart, 6th June 2016 – An international audience of professionals at HFA 2016 – Heart Failure Annual Meeting was updated by the Charité Universitätsmedizin Berlin on the latest Clinical data for Cardiac Contractility Modulation (CCM™) Therapy delivered by the Optimizer® device. Heart Failure is the annual congress of the European Society of Cardiology’s Heart Failure […]

Mehr dazu

CCM Therapy in ESC Guidelines for Diagnosis and Treatment of CHF

Stuttgart– May 22, 2016 – Cardiac Contractility Modulation (CCM) Therapy delivered by the Optimizer System has, for the first time, been included in the European Society of Cardiology’s (ESC) 2016 guidelines for the diagnosis and treatment of acute and chronic heart failure (http://www.escardio.org/Guidelines-&-Education/Clinical-Practice-Guidelines/Acute-and-Chronic-Heart-Failure) released last week. CCM Therapy is based on non-excitatory electric pulses that […]

Mehr dazu

Impulse Dynamics Completes $30 Million Financing Round

Mt. Laurel, New Jersey, May 13 2016 – Impulse Dynamics, developer of the Optimizer™ IVs implantable device for treatment of chronic heart failure (CHF), announced today that the company has closed a $30 million financing round. The equity financing round was led by the investment fund of Dr. Peter Lee Ka Kit, Vice Chairman of […]

Mehr dazu
Seite 3 von 912345...Letzte »